100% agree. Someone said it was heavily oversubscribed at 200 million dollars. If true, they could have raised at .45 cents. I think they have not acted in the best interest of shareholders and deprived them of legitimate price gain to look after their mate. This company would probably go on to make profits but will never be a world class company driven by Values.
Ann: FDA Approves Sofdra, page-266
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.5¢ |
Change
-0.010(2.99%) |
Mkt cap ! $590.6M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 33.8¢ | 31.5¢ | $1.933M | 5.941M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 261016 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 125980 | 2 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |